This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Drug candidates exhibiting atropisomerism are often considered challenging for development by pharmaceutical professionals from synthetic and regulatory perspectives. Molecules that…
Article
7 months ago ●
5 mins read
ACT-777991: next-generation CXCR3 antagonist in Phase I trials for Type 1 diabetes. ACT-777991, an oral and insurmountable CXCR3 antagonist discovered…
molecule
4 weeks ago ●
11 mins read
No time to research ideas before your next team meeting? Grab a coffee and check out these key molecules. Click…
Article
7 months ago ●
1 min read
MC4R antagonism to help gain weight. PF-07258669 is a melanocortin-4 receptor (MC4R) antagonist intended to help increase weight gain, in…
molecule
3 months ago ●
6 mins read
You’ve read about the top 10 molecules with publications from August, but what about the ones we found interesting that…
Article
8 months ago ●
8 mins read
Harnessing a novel mechanism for HIV eradication with a new class of bifunctional molecules. Modern antiretroviral therapies (ARTs) efficiently block…
molecule
3 months ago ●
5 mins read
Load More
